Exploring the role of saline nebulization in bronchiolitis: Clinical recovery, MRDAI scores, and hospital outcomes

Background: Respiratory Syncytial Virus (RSV) bronchiolitis is a significant cause of lower respiratory tract infections in infants, particularly those under two months. Supportive care is the cornerstone of management. Nebulized normal saline (0.9% sodium chloride) is often used in clinical practice, sometimes as a control in studies, but its specific impact on this age group warrants detailed documentation. Objective: This study aimed to characterize the clinical course, respiratory distress changes, and hospital outcomes in infants under two months of age with RSV-positive bronchiolitis who received nebulized normal saline as part of their care. Methods: This analysis focuses on the control group (Normal Saline-NS) of a randomized controlled trial, which included 45 infants aged ≤60 days with RSV-positive bronchiolitis. Participants in this group received nebulized 0.9% normal saline (3ml) every 8 hours. Outcomes assessed included Modified Respiratory Distress Assessment Instrument (MRDAI) scores, oxygen saturation (SpO₂), duration of oxygen therapy, and length of hospital stay. Descriptive statistics were used to present the findings. Results: The mean age of participants in the NS group was 39.21±1.50 days; 71.11% were male. MRDAI scores showed a reduction from a baseline of 6.82±1.30 to 2.31±0.13 by Day 4, with a mean difference of 4.49±1.09. SpO₂ at admission was 91.68±1.70%, and 92.16±0.14% after 24 hours. The average duration of oxygen therapy was 11.54±1.46 hours. Rapid recovery (within 72 hours) occurred in 48.8% of cases. The mean hospital stay was 79.64±3.69 hours. Conclusion: In infants ≤2 months with RSV-positive bronchiolitis, nebulized normal saline administered as part of supportive care was associated with a gradual improvement in respiratory distress and clinical recovery. These findings provide a detailed account of outcomes in this patient group receiving standard supportive management including normal saline nebulization.

Authors

Institutions

Publication Details

Journal
International Journal of Pediatrics and Neonatology
Published
2025-01-01
DOI
https://doi.org/10.33545/26648350.2025.v7.i2a.139
Primary Topic
Respiratory viral infections research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Exploring the role of saline nebulization in bronchiolitis: Clinical recovery, MRDAI scores, and hospital outcomes

Mahmuda Khanom, Mehrnaz Gerami Amin, Fahmida Ferdous, Probir Kumar Sarkar et al.
International Journal of Pediatrics and Neonatology
Respiratory viral infections research
article

Exploring the role of saline nebulization in bronchiolitis: Clinical recovery, MRDAI scores, and hospital outcomes

Mahmuda Khanom, Mehrnaz Gerami Amin, Fahmida Ferdous, Probir Kumar Sarkar, Ayesha Siddika Tonny, KM Ishtiaque Sayeed, Farhana Bhuiyan
article en

Abstract

Background: Respiratory Syncytial Virus (RSV) bronchiolitis is a significant cause of lower respiratory tract infections in infants, particularly those under two months. Supportive care is the cornerstone of management. Nebulized normal saline (0.9% sodium chloride) is often used in clinical practice, sometimes as a control in studies, but its specific impact on this age group warrants detailed documentation. Objective: This study aimed to characterize the clinical course, respiratory distress changes, and hospital outcomes in infants under two months of age with RSV-positive bronchiolitis who received nebulized normal saline as part of their care. Methods: This analysis focuses on the control group (Normal Saline-NS) of a randomized controlled trial, which included 45 infants aged ≤60 days with RSV-positive bronchiolitis. Participants in this group received nebulized 0.9% normal saline (3ml) every 8 hours. Outcomes assessed included Modified Respiratory Distress Assessment Instrument (MRDAI) scores, oxygen saturation (SpO₂), duration of oxygen therapy, and length of hospital stay. Descriptive statistics were used to present the findings. Results: The mean age of participants in the NS group was 39.21±1.50 days; 71.11% were male. MRDAI scores showed a reduction from a baseline of 6.82±1.30 to 2.31±0.13 by Day 4, with a mean difference of 4.49±1.09. SpO₂ at admission was 91.68±1.70%, and 92.16±0.14% after 24 hours. The average duration of oxygen therapy was 11.54±1.46 hours. Rapid recovery (within 72 hours) occurred in 48.8% of cases. The mean hospital stay was 79.64±3.69 hours. Conclusion: In infants ≤2 months with RSV-positive bronchiolitis, nebulized normal saline administered as part of supportive care was associated with a gradual improvement in respiratory distress and clinical recovery. These findings provide a detailed account of outcomes in this patient group receiving standard supportive management including normal saline nebulization.

International Journal of Pediatrics and NeonatologyVol. 7(2)
Bangladesh Shishu (Children) Hospital & Institute (BD), National Institute of Cardiovascular Diseases (PK), National Institute of Cardiovascular Diseases (BD), Kursk State Medical University (RU), Ministry of Health and Family Welfare (BD), Dhaka Medical College and Hospital (BD)
Openalex Percentile: Top 76%
Respiratory viral infections research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.